AdvSM: Module

CE / CME

Expert Perspectives on Incorporating Targeted Therapies Into Multidisciplinary Management of Advanced Systemic Mastocytosis

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Nurses: 1.00 Nursing contact hour

Released: April 12, 2022

Expiration: April 11, 2023

Prithviraj Bose
Prithviraj Bose, MD
Ilene A. Galinsky
Ilene A. Galinsky, NP
Caitlin R Rausch
Caitlin R Rausch, PharmD, BCOP

Activity

Progress
1
Course Completed

In this module developed for the multidisciplinary care team, Prithviraj Bose, MD, reviews key data and guidance on the optimal management of advanced systemic mastocytosis (SM), from diagnosis and classification to current and emerging therapeutic strategies. Pharmacist Caitlin R. Rausch, PharmD, and Nurse Practitioner Ilene A. Galinsky, NP, provide multidisciplinary supportive care considerations for patients with advanced SM.

The key points discussed in this module are illustrated with thumbnails from an accompanying downloadable PowerPoint slideset that can be found here or downloaded by clicking any of the slide thumbnails in this module alongside the expert commentary.

Clinical Care Options plans to measure the educational impact of this activity. Several questions will be asked twice: once at the beginning of the activity and then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

If you are a practicing healthcare professional, how many patients with advanced systemic mastocytosis do you provide care for in a typical year?

When a patient presents with suspected SM, all of the following diagnostic tests should be performed except: